The review addresses clinical studies on the botanical formulas’ effects on gut motility, microbioal balance, inflammation, and overall digestive well-being.
This confirmation expands upon the FDA's previous No Objection Letters for Nascent's Reb A to now include all steviol glycosides extracted from the leaf.
A global industry survey conducted by Nutrify Today and Baker Dillon Group reveals optimism regarding the use of new technologies in food and supplements.
Oral solids remain the preferred route of drug delivery due to their cost-effectiveness, ease of manufacturing, and patient-friendly dose form options.